TITLE

Are cardiac risks of rosiglitazone legitimate?

AUTHOR(S)
Kuznar, Wayne
PUB. DATE
July 2007
SOURCE
Drug Topics;7/23/2007, Vol. 151 Issue 14, p25
SOURCE TYPE
Trade Publication
DOC. TYPE
Proceeding
ABSTRACT
The article highlights the 67th Annual Scientific Sessions of the American Diabetes Association (ADA) held in Chicago, Illinois. Physician Steven E. Nissen discusses the results of a meta-analysis showing excess hazard of myocardial infarction found with rosiglitazone. Physician Timothy Davis presents his analysis of patients with type 2 diabetes showing that statins and fibrates lower the risk of peripheral neuropathy. Physican Harold Bays discusses his study of colesevelam HCl.
ACCESSION #
26131621

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics